The role of MARCH9 in colorectal cancer progression

Colorectal cancer (CRC) is the third most common cancer with a high global incidence and mortality. Mutated genes or dysregulated pathways responsible for CRC progression have been identified and employed as biomarkers for diagnosis and prognosis. In this study, a ubiquitination regulator, MARCH9, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hua, Chen, Biao, Liu, Lian-Lin, Cong, Lin, Cheng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523723/
https://www.ncbi.nlm.nih.gov/pubmed/36185211
http://dx.doi.org/10.3389/fonc.2022.906897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523723/
https://www.ncbi.nlm.nih.gov/pubmed/36185211
http://dx.doi.org/10.3389/fonc.2022.906897

Ejemplares similares